Literature DB >> 29609859

Cognitive behavioral therapies and multiple sclerosis fatigue: A review of literature.

Moussa A Chalah1, Samar S Ayache2.   

Abstract

BACKGROUND: Patients with multiple sclerosis (MS) commonly suffer from fatigue, a multidimensional symptom with physical, cognitive and psychosocial components that can drastically alter the quality of life. Despite its debilitating nature, the current treatment options are limited by their modest efficacy and numerous side effects. Cognitive behavioral therapies (CBT) have been applied in MS patients and might be of help in relieving fatigue. This constitutes the main objective of the current review.
METHODS: Computerized databases (Medline/PubMed, Scopus) were consulted till January 2018, and a research was conducted according to PRISMA guidelines in order to identify original research articles published at any time in English and French languages on cognitive behavioral therapies and MS fatigue as a primary outcome. The following key terms were used: ('multiple sclerosis' OR 'MS') AND ('fatigue') AND ('cognitive behavioral therapy' OR 'CBT' OR 'cognitive therapy' OR 'CT' OR 'behavioral therapy' OR 'BT' OR 'psychotherapy').
RESULTS: Fourteen papers matched the above criteria (11 trials, 2 methods and 1 study addressing CBT mechanisms of action). CBT seems to have positive effects on MS fatigue. However, the onset and duration of effects varied across the studies.
CONCLUSION: These data highlight the promising effects of CBT in MS fatigue. Admitting the limited number of studies, more protocols are needed before drawing any conclusion. Future works might benefit from combining CBT with emerging therapies such as non-invasive brain stimulation techniques which also yielded promising results in the setting of MS. This may help in long-term maintenance of fatigue relief.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behavioral therapy; CBT; Cognitive behavioral therapies; Cognitive therapy; Fatigue; Multiple sclerosis

Mesh:

Year:  2018        PMID: 29609859     DOI: 10.1016/j.jocn.2018.03.024

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Characterizing fatigue phenotypes with other symptoms and clinically relevant outcomes among people with multiple sclerosis.

Authors:  Matthew Plow; Douglas D Gunzler; Julia H C Chang
Journal:  Qual Life Res       Date:  2022-08-18       Impact factor: 3.440

2.  What Fatigue Means to Persons Living with Parkinson's Disease? A Qualitative Study.

Authors:  Derek D George; Nicholas K Baer; Jean M Berliner; Jacqueline Jones; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2021-07-07

3.  Effectiveness of Group Counseling with a Client-Centered Approach Based on the GATHER Principles on Sexual Satisfaction in Women with Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Shabnam Sazesh; Sara Esmaelzadeh Saeieh; Malihe Farid; Mansoureh Refaei; Mansoureh Yazdkhasti
Journal:  Iran J Med Sci       Date:  2021-03

Review 4.  Strategies for Behavioral Research in Neurology: Lessons Learned During the COVID-19 Pandemic and Applications for the Future.

Authors:  Ami Z Cuneo; Kazi Maisha; Mia T Minen
Journal:  Curr Neurol Neurosci Rep       Date:  2021-10-27       Impact factor: 5.081

Review 5.  Fatigue in Multiple Sclerosis: A Review of the Exploratory and Therapeutic Potential of Non-Invasive Brain Stimulation.

Authors:  Samar S Ayache; Nicolas Serratrice; Georges N Abi Lahoud; Moussa A Chalah
Journal:  Front Neurol       Date:  2022-04-28       Impact factor: 4.003

Review 6.  Moral Judgment: An Overlooked Deficient Domain in Multiple Sclerosis?

Authors:  Samar S Ayache; Moussa A Chalah
Journal:  Behav Sci (Basel)       Date:  2018-11-16

7.  Changes in plant function and root mycobiome caused by flood and drought in a riparian tree.

Authors:  Clara Martínez-Arias; Juan Sobrino-Plata; David Macaya-Sanz; Natalie Marie Aguirre; Carmen Collada; Luis Gil; Juan Antonio Martín; Jesús Rodríguez-Calcerrada
Journal:  Tree Physiol       Date:  2020-06-30       Impact factor: 4.196

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.